CannIntelligence.com provides independent, in-depth regulatory and market data and intelligence for the global cannabis and cannabinoid sector.
LATEST ALERTS
View all Cannabis and cannabinoids in South Dakota
Regulatory reports
Comprehensive legal reports outlining how the sector is regulated, interpretation of the laws and relevant bodies
Regulatory databases
Regularly updated global regulations currently in place, compiled into easy-to-read maps and tables
New trial available: Click on any alert below and access our regulatory alerts and get timely notifications sent to your inbox for 7 days.
Daily news alerts
Our legal experts track the evolving regulation around the cannabinoid and cannabis sector on a daily basis. These alerts are then compiled into our Round-up section.
24th March 2023
US - South Dakota: House Bill (HB) 1209 has been vetoed by governor Kristi Noem. HB 1209 would have revised provisions on industrial hemp by requiring containers holding in-process hemp during transport to have a label stating that it is in process and not intended for human consumption, and by increasing the total delta-9 THC cap from 1% to 5% for hemp materials being processed by a licensee. Noem explained that the reason for the veto was raising the THC threshold for in-process hemp.24th March 2023
- US - South Dakota: House Bill (HB) 1053 has been signed by the governor and enacted into law. HB 1053 will prohibit the issuance of a written certification to obtain medical cannabis “to a patient who is pregnant or breastfeeding”.
24th March 2023
- US - South Dakota: Senate Bill (SB) 1 has been signed by the governor and enacted into law. SB 1 would add eight specific qualifying conditions for medical cannabis: cancer, epilepsy, MS, ALS, PTSD, Crohn’s disease, AIDS, and HIV. The bill would also remove the process for citizens to petition to add qualifying conditions and allow the Legislature to determine which ailments or disorders qualify for medical cannabis treatment.
9th March 2023
- US - South Dakota: Senate Bill (SB) 1 has been concurred by both chambers and now heads to the governor’s desk. SB 1 would add eight specific qualifying conditions for medical cannabis: cancer, epilepsy, MS, ALS, PTSD, Crohn’s disease, AIDS, and HIV. The bill would also remove the process for citizens to petition to add qualifying conditions and allow the Legislature to determine which ailments or disorders qualify for medical cannabis treatment.
8th March 2023
US – South Dakota: House Bill 1209 is with the governor after being passed by the Senate. It would require containers holding in-process hemp during transport to have a label stating that it is in process and not intended for human consumption. It would also repeal a requirement for the state attorney general to present a report on how legalising hemp has affected enforcement of other controlled substances law, such as cannabis prosecutions.
8th March 2023
US – South Dakota: House Bill 1150 has been signed by the governor and enacted into law. It waives a medical cannabis patient’s fee for a second written certification after a follow-up assessment with their doctor. The fee can be waived once per calendar year.
7th March 2023
US – South Dakota: House Bill 1053, which would prohibit written certification to obtain medical cannabis “to a patient who is pregnant or breastfeeding”, has been passed by the Senate and now heads to the governor’s desk.
7th March 2023
US – South Dakota: Senate Bill 1 has been passed by the House in an amended version that must be reconciled with the Senate version before the bill heads to the governor’s desk. It would add eight specific qualifying conditions for medical cannabis: cancer, epilepsy, multiple sclerosis, amyotrophic lateral sclerosis (ALS), post-traumatic stress disorder (PTSD), Crohn’s disease, Aids, and HIV. In the House version, glaucoma was removed from the list. The bill would also remove the process for citizens to petition to add qualifying conditions and allow the Legislature to determine which ailments or disorders qualify for medical cannabis treatment.
2nd March 2023
US - South Dakota: House Bill 1150 has been passed by the Senate and now heads to the governor’s desk. HB 1150 would waive a medical cannabis patient’s fee for a second written certification after a follow-up assessment with their doctor. The fee can be waived once per calendar year.
28th February 2023
US - South Dakota: House Bill 1209 has been passed by the Senate and now heads to the governor’s desk. It would revise provisions on industrial hemp by requiring containers holding in-process hemp during transport to have a label stating that it is in process and not intended for human consumption, and by increasing the total delta-9 THC cap from 1% to 5% for hemp materials being processed by a licensee.
22nd February 2023
US - South Dakota: House Bill 1226, which has been passed by the House and now heads to the Senate, would require the Department of Health to establish labelling, marketing, packaging and testing requirements for products containing intoxicating hemp-derived cannabinoids, such as delta-8 and delta-10 THC.
